Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

azimilide

Known as: 2,4-Imidazolidinedione, 1-(((5-(4-chlorophenyl)-2-furanyl)methylene)amino)-3-(4-(4-methyl-1-piperazinyl)butyl)-, azmilide 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
Background—Depressed left ventricular function (LVF) and low heart rate variability (HRV) identify patients at risk of increased… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Background—Although implanted cardioverter defibrillators (ICDs) effectively treat sustained ventricular tachyarrhythmias, up to… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Background—Asymptomatic, or “silent” atrial fibrillation could increase the risk of stroke. Little is known about the frequency… Expand
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND Asymptomatic, or "silent" atrial fibrillation could increase the risk of stroke. Little is known about the frequency… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Torsade de Pointes arrhythmias are a feared proarrhythmic effect of (antiarrhythmic) drugs. In dogs with chronic complete AV… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
OBJECTIVES The purpose of this study was to assess the effectiveness of azimilide, a class III antiarrhythmic drug, in reducing… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
1998
Highly Cited
1998
The class III antiarrhythmic azimilide has previously been shown to inhibit IKs and IKr in guinea‐pig cardiac myocytes and IKs… Expand
Is this relevant?
Highly Cited
1998
Highly Cited
1998
The AzimiLide post-Infarct surVival Evaluation (ALIVE) trial is a new clinical trial using an innovative design to examine the… Expand
Is this relevant?
Highly Cited
1998
Highly Cited
1998
OBJECTIVES This study was designed to evaluate how the atrial electrophysiological and antiarrhythmic effects of azimilide… Expand
  • table 1
  • figure 1
  • figure 3
  • table 2
  • table 3
Is this relevant?
Highly Cited
1995
Highly Cited
1995
We studied the effects of NE-10064 (azimilide), a new antiarrhythmic agent reported to be a selective blocker of the slowly… Expand
Is this relevant?